Priority Date: 06.06.12 (EP 20120305636)

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CANCER

  • Application ID: EP13730146
  • Status: GRANT OF PATENT INTENDED

Attorneys

no operation time available
Headquarter in Paris
Technology Transfer Office
Employment test 201 - 500 employees
Company dna cabinet plasseraud
operating since 1906
Headquarter in Paris and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Inserm Transfert is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 06.06.2012 - Priority Date (EP 20120305636)
  • 12.12.2013 - Publication A1 (WO2013182650)
  • 15.04.2015 - Publication A1 (EP2858660)

IPC Classification